162 related articles for article (PubMed ID: 29908546)
1. Sublingual Immunotherapy with Sal k1 Expressing Lactococcus lactis Down-regulates Th2 Immune Responses in Balb/c Mice.
Ghasemi Z; Varasteh AR; Moghadam M; Jalali SA; Anissian A; Sankian M
Iran J Allergy Asthma Immunol; 2018 Jun; 17(3):281-290. PubMed ID: 29908546
[TBL] [Abstract][Full Text] [Related]
2. Production of Recombinant Protein of Salsola Kali (Sal k1) Pollen Allergen in Lactococcus Lactis.
Ghasemi Z; Varasteh AR; Moghadam M; Sedghi F; Jabbariazad F; Sankian M
Iran J Allergy Asthma Immunol; 2018 Apr; 17(2):134-143. PubMed ID: 29757586
[TBL] [Abstract][Full Text] [Related]
3. Oral Immunotherapy Using Probiotic Ice Cream Containing Recombinant Food-Grade
Vasiee A; Falah F; Sankian M; Tabatabaei-Yazdi F; Mortazavi SA
J Immunol Res; 2020; 2020():2635230. PubMed ID: 33029537
[TBL] [Abstract][Full Text] [Related]
4. Design and evaluation of a hypoallergenic peptide-based vaccine for Salsola kali allergy.
Tabesh S; Fanuel S; Fazlollahi MR; Yekaninejad MS; Kardar GA; Razavi SA
Int Immunopharmacol; 2019 Jan; 66():62-68. PubMed ID: 30445308
[TBL] [Abstract][Full Text] [Related]
5. Subcutaneous and Sublingual Immunotherapy in a Mouse Model of Allergic Asthma.
Hesse L; Nawijn MC
Methods Mol Biol; 2017; 1559():137-168. PubMed ID: 28063043
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of Th2 immune responses by sublingual administration of poly (lactic-co-glycolic) acid (PLGA)-encapsulated allergen in BALB/c mice.
Salari F; Varasteh AR; Vahedi F; Hashemi M; Sankian M
Int Immunopharmacol; 2015 Dec; 29(2):672-678. PubMed ID: 26404189
[TBL] [Abstract][Full Text] [Related]
7. Lactococcus lactis harbouring Ara h 2.02 alleviates allergen-specific Th2-associated responses in sensitized mice.
Chan CJ; Yong YS; Song AAL; Abdul Rahim R; In LLA; Lim RLH
J Appl Microbiol; 2020 Mar; 128(3):862-874. PubMed ID: 31758869
[TBL] [Abstract][Full Text] [Related]
8. Subcutaneous immunotherapy suppresses Th2 inflammation and induces neutralizing antibodies, but sublingual immunotherapy suppresses airway hyperresponsiveness in grass pollen mouse models for allergic asthma.
Hesse L; Brouwer U; Petersen AH; Gras R; Bosman L; Brimnes J; Oude Elberink JNG; van Oosterhout AJM; Nawijn MC
Clin Exp Allergy; 2018 Aug; 48(8):1035-1049. PubMed ID: 29752757
[TBL] [Abstract][Full Text] [Related]
9. DC-targeted gold nanoparticles as an efficient and biocompatible carrier for modulating allergic responses in sublingual immunotherapy.
Sadeghi M; Koushki K; Mashayekhi K; Ayati SH; Keshavarz Shahbaz S; Moghadam M; Sankian M
Int Immunopharmacol; 2020 Sep; 86():106690. PubMed ID: 32585607
[TBL] [Abstract][Full Text] [Related]
10. Enhanced sublingual immunotherapy by TAT-fused recombinant allergen in a murine rhinitis model.
Salari F; Vahedi F; Varasteh AR; Ketabdar H; Chamani J; Sankian M
Int Immunopharmacol; 2017 Jul; 48():118-125. PubMed ID: 28501765
[TBL] [Abstract][Full Text] [Related]
11. Engineered recombinant ovomucoid third domain can modulate allergenic response in Balb/c mice model.
Rupa P; Mine Y
Biochem Biophys Res Commun; 2006 Apr; 342(3):710-7. PubMed ID: 16494843
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of sublingual vectorized recombinant Bet v 1a in a mouse model of birch pollen allergic asthma.
Tourdot S; Airouche S; Berjont N; Moussu H; Betbeder D; Nony E; Bordas-Le Floch V; Baron-Bodo V; Mascarell L; Moingeon P
Vaccine; 2013 May; 31(23):2628-37. PubMed ID: 23583462
[TBL] [Abstract][Full Text] [Related]
13. Expression of the recombinant major allergen of Salsola kali pollen (Sal k 1) and comparison with its low-immunoglobulin E-binding mutant.
Assarehzadegan MA; Sankian M; Jabbari F; Tehrani M; Varasteh A
Allergol Int; 2010 Jun; 59(2):213-22. PubMed ID: 20414052
[TBL] [Abstract][Full Text] [Related]
14. A recombinant Sal k 1 isoform as an alternative to the polymorphic allergen from Salsola kali pollen for allergy diagnosis.
Mas S; Boissy P; Monsalve RI; Cuesta-Herranz J; Díaz-Perales A; Fernández J; Colás C; Rodríguez R; Barderas R; Villalba M
Int Arch Allergy Immunol; 2015; 167(2):83-93. PubMed ID: 26202069
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy with a recombinant hybrid molecule alleviates allergic responses more efficiently than an allergenic cocktail or pollen extract in a model of chenopodium album allergy.
Nouri HR; Sankian M; Afsharzadeh D; Varasteh A
Int Arch Allergy Immunol; 2013; 161(4):325-32. PubMed ID: 23689669
[TBL] [Abstract][Full Text] [Related]
16. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production.
Cosmi L; Santarlasci V; Angeli R; Liotta F; Maggi L; Frosali F; Rossi O; Falagiani P; Riva G; Romagnani S; Annunziato F; Maggi E
Clin Exp Allergy; 2006 Mar; 36(3):261-72. PubMed ID: 16499636
[TBL] [Abstract][Full Text] [Related]
17. Sublingual administration of liposomes enclosing alpha-galactosylceramide as an effective adjuvant of allergen immunotherapy in a murine model of allergic rhinitis.
Suzuki S; Sakurai D; Sakurai T; Yonekura S; Iinuma T; Okuma Y; Ihara F; Arai T; Hanazawa T; Fukuda-Kawaguchi E; Ishii Y; Okamoto Y
Allergol Int; 2019 Jul; 68(3):352-362. PubMed ID: 30803854
[TBL] [Abstract][Full Text] [Related]
18. House Dust Mite-Specific Sublingual Immunotherapy Prevents the Development of Allergic Inflammation in a Mouse Model of Experimental Asthma.
Hagner S; Rask C; Brimnes J; Andersen PS; Raifer H; Renz H; Garn H
Int Arch Allergy Immunol; 2016; 170(1):22-34. PubMed ID: 27287860
[TBL] [Abstract][Full Text] [Related]
19. Grass tablet sublingual immunotherapy downregulates the TH2 cytokine response followed by regulatory T-cell generation.
Suárez-Fueyo A; Ramos T; Galán A; Jimeno L; Wurtzen PA; Marin A; de Frutos C; Blanco C; Carrera AC; Barber D; Varona R
J Allergy Clin Immunol; 2014 Jan; 133(1):130-8.e1-2. PubMed ID: 24290282
[TBL] [Abstract][Full Text] [Related]
20. Oral administration of allergen extracts from mugwort pollen desensitizes specific allergen-induced allergy in mice.
Ma WJ; Bao MJ; Zhu JP; Yao HY; Xie YC; Guan Y; Li FF; Dong XW; Zheng YM; Xie QM
Vaccine; 2012 Feb; 30(8):1437-44. PubMed ID: 22240342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
